{
    "organizations": [],
    "uuid": "a089d08ba571192244cb7c5918627a63195c22ea",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/buzz-onconova-panel-recommends-co-to-con/buzz-onconova-panel-recommends-co-to-continue-late-stage-blood-cancer-drug-study-idUSL3N1PC4A9",
    "ord_in_thread": 0,
    "title": "BUZZ-Onconova: Panel recommends co to continue late-stage blood cancer drug study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "** Cancer drug developer’s shares up as much as 53.16 pct to $2.67 - biggest intraday pct gain in more than 3 months\n** Says an independent data monitoring committee (IMDC) recommended co to continue its late-stage study of its lead drug, rigosertib, in patients with higher-risk myelodysplastic syndromes\n** IMDC recommends co to increase enrollment by adding 135 patients to the original target to reach a total enrollment of 360 patients\n** Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells\n** In 2014, rigosertib failed to improve overall survival in late-stage trial in high risk myelodysplastic syndrome patients\n** Up to Tuesday’s close, stock had fallen about 36 pct in the past twelve months (Reporting by Akankshita Mukhopadhyay in Bengaluru)\n ",
    "published": "2018-01-17T23:59:00.000+02:00",
    "crawled": "2018-01-18T16:06:51.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "cancer",
        "drug",
        "developer",
        "share",
        "much",
        "pct",
        "biggest",
        "intraday",
        "pct",
        "gain",
        "month",
        "say",
        "independent",
        "data",
        "monitoring",
        "committee",
        "imdc",
        "recommended",
        "co",
        "continue",
        "study",
        "lead",
        "drug",
        "rigosertib",
        "patient",
        "myelodysplastic",
        "syndrome",
        "imdc",
        "recommends",
        "co",
        "increase",
        "enrollment",
        "adding",
        "patient",
        "original",
        "target",
        "reach",
        "total",
        "enrollment",
        "patient",
        "myelodysplastic",
        "syndrome",
        "group",
        "cancer",
        "immature",
        "blood",
        "cell",
        "bone",
        "marrow",
        "mature",
        "become",
        "healthy",
        "blood",
        "cell",
        "rigosertib",
        "failed",
        "improve",
        "overall",
        "survival",
        "trial",
        "high",
        "risk",
        "myelodysplastic",
        "syndrome",
        "patient",
        "tuesday",
        "close",
        "stock",
        "fallen",
        "pct",
        "past",
        "twelve",
        "month",
        "reporting",
        "akankshita",
        "mukhopadhyay",
        "bengaluru"
    ]
}